Clinical trial
A Prospective Controlled Multi-Center Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)
NCT04005586 is registered in ClinicalTrials.gov with RxSight, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Controlled Multi-Center Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)
- Lead sponsor
- RxSight, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2019
- Completion date
- March 1, 2020
- Enrollment
- 25 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.